Dyslipidemia trials

Lipid research clinics cholestyramine trial
- not specifiec
- cholystermine vs placebo
Helsinki Heart Study
- Primary prevention
- Gemfibrazole 600mg BID vs placebo
VA-HIT
- Secondary prevention
- Gemfibrazole 1200mg vs placebo
Coronary Dryg Proect Nicotinic Acid
- SEcondary Prevention
- Nicotinic acit 3000mg vs placebo
WOSCOPS
- Primary prevention
- Pravastatin 40 mg vs placebo
AFCAPS/TexCAPS
- Primary prevention
- LOvastatin 20-40 vs placeo
ASCOT-LLA
- Primary Prevention
- Atorvastatin 10mg vs placebo
Heart protection study
- Mixed (coronoary disease, AVD or DM)
- Simvastatin 40mg vs placebo
PROVE-IT
- Secondary Prevention
- Atrovastatin 80 vs pravastatin 40
fluvastatin

40-80
pravastatin

40
lovastatin

40
simvastatin

20-40
atorvastatin

10
rouvastatin

5-10
pitvastatin

2

Author

mminnick

108847

Card Set

Dyslipidemia trials

Description

IP-5

Updated

2011-10-14T04:43:10Z

Show Answers